Sovran Advisors, LLC Abbott Laboratories Transaction History
Sovran Advisors, LLC
- $954 Billion
- Q2 2025
A detailed history of Sovran Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sovran Advisors, LLC holds 8,456 shares of ABT stock, worth $1.07 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
8,456
Previous 8,279
2.14%
Holding current value
$1.07 Million
Previous $1.08 Billion
3.99%
% of portfolio
0.12%
Previous 0.14%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,572Shares Held
1.37BCall Options Held
9.75MPut Options Held
8.87M-
Vanguard Group Inc Valley Forge, PA170MShares$21.5 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.6 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.81 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.44 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.41 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $221B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...